Mario Kreutzfeldt

Title: The Innovative Contributions of Mario Kreutzfeldt

Introduction

Mario Kreutzfeldt is a notable inventor based in Carouge, Switzerland. He has made significant contributions to the field of virology, particularly in the development of vaccine vectors. His work focuses on the engineering of arenaviruses, which are crucial for advancing immunotherapy and vaccine development.

Latest Patents

Kreutzfeldt holds a patent for "Tri-segmented arenaviruses as vaccine vectors." This patent describes arenaviruses with rearrangements of their open reading frames (ORF) in their genomes. Specifically, it details a modified arenavirus genomic segment engineered to carry a viral ORF in a position other than its wild-type position. The patent also covers trisegmented arenavirus particles comprising one L segment and two S segments or two L segments and one S segment. These arenaviruses may be suitable for vaccines and treatments of diseases, as well as for use in immunotherapies. He has 1 patent to his name.

Career Highlights

Kreutzfeldt is affiliated with the Université de Genève, where he conducts his research and development work. His innovative approach to vaccine vectors has positioned him as a key figure in the field of virology.

Collaborations

Throughout his career, Kreutzfeldt has collaborated with esteemed colleagues such as Daniel David Pinschewer and Doron Merkler. These collaborations have further enhanced the impact of his research in the scientific community.

Conclusion

Mario Kreutzfeldt's contributions to the field of virology, particularly through his patent on tri-segmented arenaviruses, highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new vaccine technologies and therapeutic approaches.